Úvod: Současné doporučené postupy Evropské kardiologické společnosti podporující invazivní léčbu akutního koronárního syndromu bez elevací úseku ST (non-STE AKS) jsou založeny na modelu stanovení rizika GRACE. Cíl: Cílem této studie bylo zjistit, zda léčba non-STE AKS perkutánní koronární intervencí snižuje dlouhodobou mortalitu hodnocenou podle skóre rizika GRACE. Metody: Provedli jsme retrospektivní studii se vzorkem po sobě jdoucích 680 pacientů s non-STE AKS léčených s použitím PCI v Kardiocentru Semmelweis University. Skóre rizika GRACE se vypočítávalo při příjmu každého pacienta. Byla stanovena průměrná hodnota relativního rizika v každé skupině a porovnána s dlouhodobým klinickým výsledkem léčby (sledována šestiměsíční mortalita). Výsledky: Průměrná hodnota vypočítaného skóre GRACE byla 1,6 % u pacientů s nízkým rizikem, 5,0 % u nemocných se středně vysokým rizikem a 21,3 % u pacientů s vysokým rizikem. Naproti tomu dosáh-lo zjištěné riziko úmrtí do šesti měsíců hodnoty 0,42 % u pacientů s nízkým rizikem, 1,1 % u nemocných se středně vysokým rizikem, a 12,6 % u vysoce rizikových pacientů. Rozdíl mezi vypočítanou a zjištěnou šestiměsíční mortalitou ve skupinách se středně vysokým a vysokým rizikem byl statisticky významný (střední riziko, p = 0,004; vysoké riziko, p = 0,0097). Skutečné riziko úmrtí u nemocných s nízkým rizikem bylo rovněž nižší -ne však statisticky významně -než vypočítané riziko. Závěr: Riziko úmrtí pacientů s non-STE AKS léčených na pracovišti s vysokým počtem každoročně ošetřované této pacientské populace bylo statisticky významně nižší než riziko stanovené pomocí modelu rizika GRACE. Naše výsledky naznačují, že provádění perkutánní koronární intervence po non-STE AKS na základě rizika stanoveného pomocí modelu rizika GRACE je nejpřínosnější u nemocných se středně vysokým a vysokým rizikem.
Introduction
At least 70% of acute coronary patients are classifi ed as those with either unstable angina or non-ST segment elevation myocardial infarction (NSTE-ACS) [1, 2] . Despite secondary prevention including pharmacological treatment [3] and optimal cardiac rehabilitation [4] the long-term outcomes of patients with unstable angina or NSTEMI are equal or worse [5] [6] [7] [8] [9] than the outcomes in ST-segment elevation myocardial infarction [10] . These consequences are a result of increased age and further evidence of comorbidity such as diabetes mellitus, chronic kidney disease, previous myocardial infarction, coronary artery bypass graft surgery or advanced coronary disease. Consequently the risk stratifi cation plays a key role in the management of NSTE-ACS [11] [12] [13] [14] [15] [16] [17] [18] [19] . The Global Registry of Acute Coronary Events (GRACE) risk model enables professionals to assess the risk of death and it also provides a guide to the invasive therapy [11, [20] [21] [22] [23] [24] [25] [26] .
The aim of the study was to determine whether the percutaneous coronary intervention treatment in NSTE--ACS could improve the long-term mortality according to the estimated GRACE risk score.
Methods

Study population
The study population included 690 consecutive patients with NSTE-ACS treated by PCI in the Heart Center of Semmelweis University Budapest, Hungary. Eligible patients were at least 18 years old and were admitted to the hospital with a presumptive NSTE-ACS which was verifi ed. Each one of them was treated with percutaneous coronary intervention.
Patient stratifi cation
The cohort of the present study (n = 690) was stratifi ed on the basis of predefi ned cut-off points of the GRACE risk score into low, medium and high risk groups. The GRACE risk model is composed of the following predictor variables on presentation: age, heart rate, systolic blood pressure, cardiac arrest, Killip class, creatinine, ST segment deviation and biomarker status [27] . Points are scored according to set variables for each element, and the sum of the points equates to the GRACE risk score. All of the risk groups were divided into further subgroups by age: under 65 years, between 65 and 75 years, and above 75 years.
Statistics
Comparison of the predictor variables between the international GRACE patient population and the patients treated in the Semmelweis University Heart Center was made by 2 test. The mean of the individual GRACE risk scores was calculated in each risk group. 2 test was used for comparison of assessed and observed risk of death. All calculations were done with Excel 2009 (Microsoft Inc. Seattle, USA).
Results
Baseline clinical characteristics of 690 patients with NSTE--ACS treated with PCI in the Heart Center of Semmelweis
Results: The mean of calculated GRACE amounts 1.6% for low risk patients, 5.0% for medium risk patients, and 21.3% for patients with high risk. In contrast, the observed risk of 6-month death was 0.42% for low risk patients, 1.1% for medium risk patients, and 12.6% for patients with high risk. Difference between assessed and observed 6-month mortality in high risk and medium risk groups was signifi cant (medium risk p = 0.004; high risk p = 0.0097). Observed risk of death in low risk patients was also lower, but not signifi cant than assessed risk. Conclusion: The risk of death in patients with NSTE-ACS treated in high volume center is signifi cantly lower than predicted by GRACE risk model. Our results suggest that percutaneous coronary intervention treatment guided by GRACE risk model in medium and high risk patents with NSTE-ACS provides the greatest clinical benefi t.
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Table 1 -Baseline clinical characteristic of patients in Heart Center of Semmelweis University (HC-SE) and GRACE NSTE-ACS study (GRACE).
Patient characteristics HC-SE (n = 690) GRACE (n = 23,825)
Age (years) 67 67
Male (%) 69 65
Hypertension (%) 82* 64
Hypercholesterolemia (%) 48 51
Diabetes mellitus (%) 34* 27
Myocardial infarction (%) 51* 37
Percutaneous coronary intervention (%) 22 20 Coronary artery bypass graft (%) 12* 17
Values are n (%). GRACE -Global Registry of Acute Coronary Events; HC-SE -Heart Center of Semmelweis University. * p < 0.05.
The magnitude of PCI in high and medium risk non-ST elevation acute coronary syndrome University were compared to the characteristics of the population of GRACE NSTE-ACS registry in Table 1 . Patients of our study population were more likely to have a history of hypertension, diabetes mellitus and previous myocardial infarction. According to the calculated GRACE risk score, 184 patients were assigned to the group with high risk, 266 patients to the group with medium risk and 251 patients to the group with low risk. 27 patients died within 6 months after PCI, 22 of them showed high risk, 3 medium and only 1 patient was in the low risk group. The observed relative risk of 6-month mortality amounts to 12.6% for high risk patients, 1.1% for medium risk, and 0.4% for low risk.
The difference between assessed and observed 6-month mortality in high risk group was statistically signifi cant (p = 0.03). Observed mortality in low and medium risk group was not signifi cant but it shows a downward tendency. The patients between 65-75 years belonging to the medium risk subgroup and patients above 75 years belonging to the high risk subgroup had signifi cantly lower observed mortality than assessed risk of death (Fig. 1.) .
Discussion
The results of the present study show that the risk of death in patients with NSTE-ACS treated with PCI in a high volume center was signifi cantly lower than predicted by the GRACE risk model. After PCI the observed mortality decreased in each risk group and subgroup compared to the assessed risk of death by GRACE score, signifi cantly in patients with high risk (12.6% compared to 21.3%) and in patients between 65-75 years belonging to the medium subgroup (0.7% compared to 5.04%). The observed mortality in patients belonging to the medium risk group (1.1%) reached the level of the low risk group assessed by the GRACE risk model (1.6%). In point of mortality, patients in the medium risk group treated with PCI have fallen into the group with low risk. While our study population was more likely to have comorbidity (such as hypertension, diabetes mellitus or previous myocardial infarction) than the population studied in GRACE trial, after all the observed risk of death was lower.
Our results suggest that percutaneous coronary intervention treatment guided by expert cardiologists in a high volume interventional center provides the greatest clinical benefi t in medium and high risk patients with NSTE-ACS assessed by GRACE risk model.
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